Antimicrobial activity of gallium maltolate against Staphylococcus aureus and methicillin-resistant S. aureus and

Carolyn E Arnold1, Angela Bordin, Sara D Lawhon

  • 1Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX 77843-4475, USA. Carnold@cvm.tamu.edu

Veterinary Microbiology
|October 4, 2011
PubMed

Insights

Gallium maltolate effectively inhibited the growth of Staphylococcus aureus and methicillin-resistant strains in vitro. This finding suggests gallium

Area of Science:

  • Microbiology
  • Antimicrobial Research
  • Inorganic Chemistry

Background:

  • Gallium, a semi-metallic element, exhibits antimicrobial properties by interfering with bacterial iron-dependent metabolic pathways.
  • Staphylococcus species, including human and animal pathogens, rely on iron for growth and colonization.
  • Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus pseudintermedius (MRSP) are significant causes of morbidity and mortality.

Purpose of the Study:

  • To evaluate the in vitro antimicrobial activity of gallium maltolate against Staphylococcus aureus and MRSA.
  • To determine the efficacy of gallium maltolate against clinical isolates of MRSA and MRSP.

Main Methods:

  • In vitro growth inhibition assays were performed using various concentrations of gallium maltolate (50–200μM).
  • Bacterial growth was monitored over time (8–36 hours post-inoculation).
  • Testing included standard strains and clinical isolates of MRSA and MRSP.

Main Results:

  • Gallium maltolate demonstrated significant in vitro inhibition of Staphylococcus aureus and MRSA growth.
  • The inhibitory effect was observed at concentrations ranging from 50 to 200μM.
  • Activity was confirmed against clinical isolates of MRSA and MRSP.

Conclusions:

  • Gallium maltolate possesses potent in vitro antimicrobial activity against clinically relevant Staphylococcus species.
  • Gallium maltolate represents a potential therapeutic agent for infections caused by S. aureus, MRSA, and MRSP.
  • Further research into gallium-based compounds for treating staphylococcal infections is warranted.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...